KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 93 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $214,422 | +50.1% | 22,266 | +40.3% | 0.00% | – |
| Q2 2023 | $142,821 | +169.4% | 15,869 | +135.2% | 0.00% | – |
| Q1 2023 | $53,023 | -18.6% | 6,746 | -30.0% | 0.00% | – |
| Q4 2022 | $65,126 | +261.8% | 9,634 | +682.0% | 0.00% | – |
| Q3 2022 | $18,000 | +80.0% | 1,232 | +15.8% | 0.00% | – |
| Q2 2022 | $10,000 | -98.4% | 1,064 | -97.5% | 0.00% | – |
| Q1 2022 | $634,000 | -10.5% | 42,993 | -19.7% | 0.00% | – |
| Q4 2021 | $708,000 | +22.1% | 53,563 | +61.2% | 0.00% | – |
| Q3 2021 | $580,000 | +457.7% | 33,228 | +668.8% | 0.00% | – |
| Q2 2021 | $104,000 | -62.5% | 4,322 | -59.9% | 0.00% | – |
| Q1 2021 | $277,000 | +714.7% | 10,776 | +509.2% | 0.00% | – |
| Q4 2020 | $34,000 | +240.0% | 1,769 | +133.4% | 0.00% | – |
| Q3 2020 | $10,000 | -80.8% | 758 | -82.4% | 0.00% | – |
| Q2 2020 | $52,000 | -8.8% | 4,315 | -42.6% | 0.00% | – |
| Q1 2020 | $57,000 | -81.6% | 7,511 | -56.8% | 0.00% | – |
| Q4 2019 | $310,000 | +150.0% | 17,393 | +62.4% | 0.00% | – |
| Q3 2019 | $124,000 | +163.8% | 10,711 | +408.6% | 0.00% | – |
| Q2 2019 | $47,000 | +235.7% | 2,106 | +334.2% | 0.00% | – |
| Q1 2019 | $14,000 | 0.0% | 485 | -26.5% | 0.00% | – |
| Q3 2018 | $14,000 | -44.0% | 660 | -78.8% | 0.00% | – |
| Q2 2018 | $25,000 | +2400.0% | 3,114 | +2047.6% | 0.00% | – |
| Q1 2018 | $1,000 | -93.8% | 145 | -90.9% | 0.00% | – |
| Q4 2017 | $16,000 | +45.5% | 1,591 | +5.6% | 0.00% | – |
| Q2 2017 | $11,000 | -38.9% | 1,506 | -34.7% | 0.00% | – |
| Q1 2017 | $18,000 | +200.0% | 2,307 | +153.8% | 0.00% | – |
| Q4 2016 | $6,000 | – | 909 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 719,937 | $6,697,459 | 5.56% |
| TCG Crossover Management, LLC | 3,395,495 | $22,953,546 | 4.05% |
| VR Adviser, LLC | 2,916,667 | $19,716,669 | 3.32% |
| TANG CAPITAL MANAGEMENT LLC | 3,196,446 | $21,607,975 | 3.14% |
| Prosight Management, LP | 621,667 | $4,202,469 | 2.29% |
| Opaleye Management Inc. | 923,200 | $6,240,832 | 2.17% |
| GREAT POINT PARTNERS LLC | 1,055,801 | $7,137,215 | 1.40% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $21,894,687 | 1.36% |
| DAFNA Capital Management LLC | 616,032 | $4,164,376 | 1.17% |
| Vivo Capital, LLC | 856,008 | $5,787 | 0.67% |